1 follower
PMV Pharmaceuticals, Inc. is developing first-in-class p53 regulators for the treatment of cancer. PMV Pharma combines unique biological understanding with pharmaceutical development focus.
David H. Mack
Synthekine
3 followers
Caribou Biosciences
2 followers
Vera Therapeutics
2 followers
Neogene Therapeutics
2 followers
Kyverna Therapeutics
7 followers
Day One Biopharmaceuticals
1 follower
Aura Biosciences
1 follower
CG Oncology
1 follower
Aviceda Therapeutics
1 follower
Foresight Diagnostics
1 follower
Slingshot Biosciences
1 follower
Explore companies